Innovent Bio held a special shareholders' meeting on June 21, 2024, where a series of ordinary resolutions relating to the restricted share plan in 2020 were passed. These resolutions included the granting of restricted shares to senior management and independent non-executive directors, and authorization for directors to exercise relevant powers to allocate, issue, and deal with shares. Shareholders also approved a new share plan called the 2024 Share Plan, which will allow up to 10% of the total issued share capital to be used for reward grants. All proposals were officially passed with support from over 50% of the shareholders. The beneficiaries of the relevant restricted shares and their contacts waived their voting rights for the relevant resolutions during the meeting. The vote counting work of the special Shareholders' Meeting was carried out by Hong Kong Securities Clearing Company Limited.

Innovent Bio held a special shareholders' meeting on June 21, 2024, where a series of ordinary resolutions relating to the restricted share plan in 2020 were passed. These resolutions included the granting of restricted shares to senior management and independent non-executive directors, and authorization for directors to exercise relevant powers to allocate, issue, and deal with shares. Shareholders also approved a new share plan called the 2024 Share Plan, which will allow up to 10% of the total issued share capital to be used for reward grants. All proposals were officially passed with support from over 50% of the shareholders. The beneficiaries of the relevant restricted shares and their contacts waived their voting rights for the relevant resolutions during the meeting. The vote counting work of the special Shareholders' Meeting was carried out by Hong Kong Securities Clearing Company Limited.